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Abstract Reproducibility of the quantitative assessment
of atherosclerosis by computed tomography coronary
angiography (CTCA) is paramount for the design of lon-
gitudinal studies. The purpose of this study was to assess
the inter- and intra-observer reproducibility using semiau-
tomated CT plaque analysis software in symptomatic
individuals. CTCA was performed in 10 symptomatic
patients after percutaneous treatment of the culprit lesions
and was repeated after 3 years. The plaque quantitative
analysis was performed in untreated vessels with mild-to-
moderate atherosclerosis and included geometrical and
compositional characteristics using semiautomated CT
plaque analysis software. A total of 945 matched cross-
sections from 21 segments were analyzed independently by
a second reviewer to assess inter-observer variability; the
first observer repeated all the analyses after 3 months to
assess intra-observer variability. The observer variability
was also compared to the absolute plaque changes detected
over time. Agreement was evaluated by Bland–Altman
analysis and concordance correlation coefficient. Inter-
observer relative differences for lumen, vessel, plaque area
and plaque burden were 1.2, 0.6, 2.2, 1.6 % respectively.
Intra-observer relative differences for lumen, vessel, pla-
que area and plaque burden were 1.0, 0.4, 0.2, 0.4 %
respectively. For the average plaque attenuation values the
inter- and intra-observer variability was 5 and 2 %
respectively. For the % low-attenuation-plaque the inter-
and intra-observer variability was 16 and 6 % respectively.
The absolute intra-observer variability for the plaque bur-
den was 1.30 ± 1.09 %, while the temporal plaque burden
difference was 3.55 ± 3.02 % (p = 0.001). The present
study shows that the geometrical assessment of coronary
atherosclerosis by CTCA is highly reproducible within and
between observers using semiautomated quantification
software and that serial plaque changes can be detected
beyond observer variability. The compositional measure-
ments are more variable between observers than geomet-
rical measurements.
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Introduction
Coronary atherosclerosis is a worldwide disease with a
burden of 17 million deaths annually [1]. In the past,
quantitative coronary angiography (QCA) [2] and intra-
vascular ultrasound (IVUS) have been used to study the
extent of the disease [3] and monitor the progression/
regression of atherosclerosis. Nevertheless, both imaging
techniques are invasive, expensive and not free of com-
plications, thus unsuitable for routine serial assessment of
atherosclerosis.
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Computed tomography coronary angiography (CTCA)
has been introduced as a noninvasive technique for athero-
sclerotic plaque quantification in vivo. To date, there are
several CTCA studies describing the extent, severity, dis-
tribution, and morphology of coronary atherosclerosis,
including several longitudinal studies assessing plaque pro-
gression/regression by CTCA [4–11].
Reproducibility of measurements is crucial for the
internal validity of longitudinal studies using CTCA; as
previous serial studies using IVUS and CTCA have shown,
the temporal changes in atherosclerotic plaque are small
[11, 12]. The use of semiautomated plaque analysis soft-
ware which can produce accurate and reproducible quan-
titative measurements can facilitate the serial assessment of
atherosclerosis by CTCA. However, only scarce data are
available about the reproducibility of quantitative mea-
surements for geometrical and compositional parameters of
atherosclerotic plaque and a comparison with serial chan-
ges in plaque parameters is lacking.
Therefore, the aims of our study were the following: (1)
to assess the inter-observer and intra-observer agreement of
plaque geometrical measurements using semiautomated
CTCA plaque analysis software; and as secondary objec-
tives (2) to investigate the influence of the variability of the
plaque contours position on the compositional measure-
ments; and (3) to compare the observer variability with the
serial changes in plaque burden and plaque area.
Methods
Patient population
In this exploratory study, the population comprised 10
randomly selected patients (21 segments and 945 cross-
sections) from a prospective cohort of symptomatic
patients; this main cohort included 32 patients with acute
coronary syndromes who underwent CTCA after percuta-
neous treatment of the culprit lesions and follow-up CTCA
after 3 years to assess plaque temporal changes in the
untreated vessels, as part of the PROSPECT MSCT sub-
study in our institution [11]. The institutional review board
approved the study and all patients gave written informed
consent.
CTCA acquisition
All patients received CT coronary angiography at baseline
and 3 years follow-up which was performed using a
64-slice single source scanner (Sensation 64, Siemens
Medical Solutions, Forchheim, Germany) and a 64-slice
dual source CT scanner (Somatom Definition, Siemens
Medical Solutions, Forchheim, Germany) respectively; the
scanning protocol has been previously described in detail
[11]. The patients received nitrates and b-blockers prior to
the scan provided there were no contraindications. The CT
angiographic scan parameters were: (1) for the single
source CT scanner a gantry rotation time of 330 ms;
32 9 2 slices per rotation; 0.6 mm detector collimation;
spiral scan mode with a table feed of 3.8 mm per rotation; a
tube voltage of 120 kV; and tube current of 900 effective
mAs. A bolus of 100 mL of contrast material (400 mgI/
mL; Iomeron, Bracco, Milan, Italy) was injected intrave-
nously at 5 mL/s flow rate followed by a saline chaser. The
initiation of the scan was synchronized to the arrival of
contrast in the coronary arteries by a bolus-tracking tech-
nique; (2) for the dual source CT scanner 32 9 2 9
0.6 mm collimation with z-flying focal spot for both
detectors, gantry rotation time 330 ms, tube voltage
120 kV and tube current of 320–412 mAs per rotation. A
bolus of iodinated contrast material (370 mgI/mL, Ultra-
vist; Schering, Berlin, Germany), which varied between 60
and 100 mL, depending on the expected scan time, was
injected intravenously (flow rate 5.5 mL/s) followed by a
40 mL saline chaser at the same injection rate. A bolus
tracking technique was used to synchronize the arrival of
contrast in the coronary arteries and the start of the
acquisition. The mean effective radiation dose was
14.0 ± 0.8 mSv for the baseline and 10.4 ± 3.0 mSv for
the follow-up scan, using the dose-length product and a
conversion factor k (0.014 mSv/mGy/cm) [13]. For all
datasets, axial images were reconstructed using retrospec-
tive ECG-gating, with a slice thickness of 0.75-mm, slice
increment of 0.4-mm and a medium-to-smooth convolution
kernel (filtered back projection method). Optimal datasets
with the best image quality were reconstructed mainly in
the mid- to end-diastolic phase.
CTCA image analysis
All datasets (baseline and follow-up) were transferred to an
offline workstation for analysis using semi-automated
plaque analysis software (QAngioCT Research Edition
v1.3.61, Medis Medical Imaging Systems, Leiden, The
Netherlands) [14]. An experienced observer (3 years
CTCA experience) blinded to the sequence of imaging
analyzed all the scans of the main study cohort; the com-
plete results of this temporal analysis have been previously
published [11]. To examine inter-observer variability of
plaque analysis a second observer (1 year CTCA experi-
ence) performed blindly the analysis on 21 segments from
10 randomly selected patients at the follow-up time point,
starting completely from the raw datasets; to examine the
intra-observer variability, the first reader re-analyzed all
the segments in a similar blinded fashion 3 months after
his/her original analysis.
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The major vessels (LAD, LCX, RCA) were considered
for analysis using the modified 17-segment American Heart
Association model for coronary segment classification
[15]. The segments were carefully matched for all the
comparisons using the bifurcations carina as landmarks.
The segments of poor quality due to stack or movement
artifacts, or severe calcification (with blooming artifacts
preventing reliable assessment of the lumen) were exclu-
ded from analysis.
Definition of the inner lumen and outer vessel areas was
performed semi-automatically following a stepwise
approach. First, a centerline originating from the ostium was
automatically extracted after an ostial proximal point and a
distal point were placed by the observer; then straightened
multi-planar reformatted images were generated and the
lumen and vessel borders were detected longitudinally in 4
different longitudinal cutplanes by the software and then
corrected by the observer. Based on these updated longitu-
dinal contours, cross-sectional images at 0.5 mm intervals
were calculated in order to create transversal lumen and
vessel wall contours, which were examined and, if necessary,
adjusted by the observer (Fig. 1). Gradient magnitude ima-
ges, which are derived from the CTCA images and display
the degree of CT density change, were used to verify the
lumen and vessel wall borders.
The following quantitative parameters were derived per
cross-section: the lumen area, the lumen diameter, the
vessel area and the plaque burden [(plaque area/vessel
area) * 100]. The plaque area was calculated by subtract-
ing lumen area from vessel area. Geometrical parameters
determined on a segmental level included the following:
the mean lumen area, the mean vessel area, the mean
plaque area, the plaque burden, the minimal lumen diam-
eter (MLD) and the minimal lumen area (MLA). The mean
areas were the averaged measurements of all cross-sections
for each segment. Furthermore, the plaque composition
was evaluated in each cross-section and in each coronary
segment based on attenuation values in HU (Hounsfield
Units); the mean HU and the % of voxels with attenuation
values \30 HU (representing low attenuation plaque—
%LAP) were calculated for each cross-section and each
coronary segment.
Observer variability and detected plaque changes
over time
In order to investigate whether the observer variability
using semi-automated analysis software is acceptable for
monitoring the longitudinal plaque changes over time, we
compared the absolute plaque change with the absolute
observer variability for each segment. In this way by
comparing the absolute differences, we can investigate
whether the magnitude of observer variability is smaller
than the magnitude of the plaque changes, while the
direction of the change (positive/negative) is irrelevant to
the comparison.
Statistical analysis
Continuous variables are presented as mean ± SD or
median (interquartile range—IQR) if not normally dis-
tributed. Discrete variables are presented as counts and/or
percentages. The analyses were performed on both cross-
sectional and segmental level. The inter-observer and intra-
observer agreement were assessed using the Lin’s con-
cordance correlation coefficient [CCC with the 95 % con-
fidence interval (CI)] [16]; Bland–Altman analysis [17]
was performed by plotting the mean against the difference
in measurements. Limits of agreement were determined by
adding 1.96 standard deviations to the mean difference for
the upper limit and by subtracting 1.96 standard deviations
from the mean difference for the lower limit. The paired
t test was used to compare the absolute plaque change with
the absolute observer variability. A two-sided p value of
less than 0.05 was used to indicate statistical significance.
Statistical analyses were performed with SPSS 17.0
software (SPSS, Chicago IL).
Results
The baseline characteristics of the included patients
(n = 10) are as follows: mean age was 56 ± 4 and 80 %
were male. Regarding cardiac risk factors, 40, 10, and 50 %
had hypertension, diabetes mellitus, and hyperlipidemia,
respectively. The untreated vessels were examined (n = 19)
and the ones with low image quality (due to motion or stack
artifacts or extremely calcified coronary arteries) were
excluded (n = 8). The analyzed vessels were the left anterior
descending (n = 4, 36 %), the left circumflex (n = 4, 36 %)
and the right coronary artery (n = 3, 27 %).
Inter-observer agreement
For the assessment of the inter-observer agreement, 945
matched cross-sections from 21 paired coronary segments
were analyzed separately by 2 independent observers.
At the cross-sectional level, the mean differences for
geometrical parameters were small (Table 1a), with narrow
limits of agreement between observers (limits of agreement
for lumen, vessel, plaque and plaque burden measurements
of 2.39, -2.03 mm2; 2.81, -2.99 mm2; 2.86, -3.41 mm2;
and 9.44, -11.10 %, respectively). The Bland–Altman
analysis is shown in Fig. 2. The concordance correlation
coefficients were high (Table 2a), except for the maximal
plaque thickness (CCC: 0.65). For the compositional
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analysis as expressed by the plaque attenuation values
(Table 3a), the median (IQR) difference of the attenuation
between observers was 6 (-4, 22) HU, which corresponds
to a median of 5 % variability. The median (IQR) differ-
ence of the %LAP was -1.6 (-6.3, 2.1), which corre-
sponds to a median of 16 % inter-observer variability.
At the segmental level, the mean differences for
geometrical parameters were also small (Table 1b), with
narrow limits of agreement between observers (limits of
agreement for lumen, vessel, plaque and plaque burden
measurements of 1.12, -0.76 mm2; 1.10, -1.26 mm2;
0.94, -1.46 mm2; and 3.64 %, -5.50 % respectively). The
concordance correlation coefficients were high (Table 2b).
For the compositional analysis as expressed by the plaque
attenuation values (Table 3a), the median (IQR) difference
of the attenuation between observers was 4 (-9, 9) HU,
which corresponds to a median of 4 % variability. The
median (IQR) difference of the %LAP was -1.7 (-3.9,
1.2), which corresponds to a median of 12 % inter-observer
variability.
Intra-observer agreement
For the assessment of the intra-observer agreement, 945
matched cross-sections from 21 paired coronary segments
were fully re-analyzed by the first observer after 3 months.
At the cross-sectional level, the mean differences for
geometrical parameters were small (Table 4a), with narrow
limits of agreement between the two rounds of analysis
(limits of agreement for lumen, vessel, plaque and plaque
burden measurements of 1.62, -1.77 mm2; 2.33,
-2.54 mm2; 2.59, -2.66 mm2; and 7.49 %, -7.15 %
respectively). The Bland–Altman analysis is shown in
Fig. 3. The concordance correlation coefficients were high
(Table 5a). For the compositional analysis as expressed by
the plaque attenuation values (Table 3b), the median (IQR)
difference of the attenuation between the two rounds of
analysis was 2 (-5, 11) HU, which corresponds to a median
of 2 % variability. The median (IQR) difference of the
%LAP was -0.7 (-3.9, 2.2), which corresponds to a median
of 6 % intra-observer variability.
Fig. 1 Example of quantitative analysis of a left anterior descending artery. The analyzed cross-sections at 3 different levels are also shown
(panels a–c)
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At the segmental level, the mean differences for
geometrical parameters were small (Table 4b), with
narrow limits of agreement between the two rounds of
analysis (limits of agreement for lumen, vessel, plaque and
plaque burden measurements of 0.83, -0.91 mm2; 0.67,
-0.81 mm2; 0.83, -0.89 mm2; and 3.55 %, -3.15 %
respectively). The concordance correlation coefficients
were very high (Table 5b). For the compositional analysis
as expressed by the plaque attenuation values (Table 3b),
the median (IQR) difference of the attenuation between the
two rounds of analysis was 1 (-1, 5) HU, which corre-
sponds to a median of\1 % variability. The median (IQR)
difference of the %LAP was -0.6 (-1.6, 0.3), which




CSA cross-sectional area, SD
standard deviation




(a). Matched cross-sections (n = 945)
Lumen CSA (mm2) 9.08 ± 4.27 9.26 ± 4.44 0.18 ± 1.13 1.2
Lumen diameter (mm) 3.31 ± 0.77 3.34 ± 0.80 0.03 ± 0.19 0.6
Vessel CSA (mm2) 19.96 ± 5.65 19.87 ± 5.71 0.09 ± 1.48 0.6
Plaque CSA (mm2) 10.88 ± 2.84 10.61 ± 2.61 0.27 ± 1.60 2.2
Plaque burden (%) 56.07 ± 10.54 55.24 ± 10.83 0.83 ± 5.24 1.6
Plaque max. thickness (mm) 1.15 ± 0.36 1.10 ± 0.39 0.05 ± 0.26 5.5
(b). Matched segments (n = 21)
Average lumen CSA (mm2) 8.92 ± 3.90 9.09 ± 4.10 0.18 ± 0.48 1.3
Average vessel CSA (mm2) 19.64 ± 5.54 19.56 ± 5.62 0.08 ± 0.60 0.6
Average plaque CSA (mm2) 10.73 ± 2.29 10.47 ± 2.20 0.26 ± 0.61 2.4
Plaque burden (%) 56.15 ± 7.97 55.22 ± 8.61 0.93 ± 2.33 1.9
Minimum lumen area (mm2) 6.12 ± 2.80 6.33 ± 3.18 0.21 ± 0.62 1.4
Minimum lumen diameter (mm) 2.72 ± 0.64 2.76 ± 0.71 0.03 ± 0.12 0.7
Fig. 2 Bland-Altman plots of inter-observer comparisons for lumen, vessel, plaque area and plaque burden
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Comparison of the observer variability with the plaque
serial changes
For the 21 segments included in the reproducibility anal-
ysis, the absolute change (irrespectively of progression or
regression) in mean plaque area between the two time
points was 1.65 ± 1.42 mm2 and the absolute change in %
plaque burden was 3.55 ± 3.02 %.
The absolute intra-observer variability for these
parameters was significantly smaller than the serial plaque
changes (0.36 ± 0.24 mm2, p \ 0.001 for mean plaque
area and 1.30 ± 1.09 %, p = 0.001 for plaque burden).
The absolute inter-observer variability for these
parameters was also smaller than the serial plaque changes
(0.51 ± 0.41 mm2, p \ 0.001 for mean plaque area and
1.99 ± 1.49 %, p = 0.044 for plaque burden).
Discussion
The purpose of this study was to assess in detail the inter-
and intra-observer reproducibility of plaque geometrical
and compositional parameters using dedicated semiauto-
mated CT plaque analysis software in vessels with mild-to-
moderate atherosclerosis. To our knowledge this is the first
Table 2 Correlation between different observers for geometrical and
compositional parameters
Geometrical and compositional parameters CCC 95 % CI
(a) Cross-sectional basis
Lumen area (mm2) 0.97 0.966–0.974
Lumen diameter (mm) 0.97 0.969–0.976
Vessel area (mm2) 0.97 0.964–0.972
Plaque area (mm2) 0.83 0.810–0.849
Plaque burden (%) 0.89 0.872–0.899
Maximal plaque thickness (mm) 0.65 0.615–0.688
Mean plaque attenuation (HU) 0.85 0.837–0.869
% LAP 0.65 0.608–0.680
(b) Segmental basis
Mean lumen area (mm2) 0.99 0.988–0.998
Mean vessel area (mm2) 0.99 0.986–0.998
Mean plaque area (mm2) 0.96 0.902–0.983
Plaque burden (%) 0.96 0.913–0.983
Minimal lumen area (mm2) 0.98 0.952–0.988
Minimal lumen diameter (mm) 0.98 0.968–0.992
Mean plaque attenuation (HU) 0.73 0.526–0.855
% LAP 0.73 0.490–0.865
CCC concordance correlation coefficient, CI confidence interval, LAP
low attenuation plaque
Table 3 Reproducibility of compositional measurements






(a). Between different observers
Cross-sections (n = 945)
Average attenuation (HU) 124 ± 45 135 ± 52 11 ± 25 6 (-4, 22) 5.1
LAP (%) 12.7 ± 8.2 10.5 ± 8.7 2.2 ± 6.9 -1.6 (-6.3, 2.1) 16.4
Segments (n = 21)
Average attenuation (HU) 125 ± 26 136 ± 39 12 ± 22 4 (-9, 9) 4.3











(b). Between the 2 rounds of the same observer
Cross-sections (n = 945)
Average attenuation (HU) 124 ± 45 126 ± 46 4 ± 22 2 (-5, 11) 1.6
LAP (%) 12.7 ± 8.2 12.1 ± 8.1 -1.0 ± 5.4 -0.7 (-3.9, 2.2) 6.1
Segments (n = 21)
Average attenuation (HU) 125 ± 26 127 ± 27 2 ± 5 1 (-1, 5) 0.5
LAP (%) 13.1 ± 5.5 12.4 ± 5.6 -0.7 ± 1.4 -0.6 (-1.6, 0.3) 2.5
IQR interquartile range, LAP low attenuation plaque, SD standard deviation
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study in which the observer variability is compared with
actual serial changes in atherosclerotic plaque size. The
main findings of the present study were as follows: (1) the
CTCA geometrical measurements were highly reproduc-
ible in both intra- and inter-observer comparisons; (2) the
compositional measurements were indeed more variable
than geometrical measurements, and mostly influenced by
the inter-observer variability; and (3) the intra- and inter-
observer variability were lower than the detected changes
in plaque burden and plaque area after 3 years.
Over the recent few years, CTCA has been more com-














(a). Matched cross-sections (n = 945)
Lumen CSA (mm2) 9.08 ± 4.27 9.00 ± 4.19 0.08 ± 0.87 1.0
Lumen diameter (mm) 3.31 ± 0.77 3.30 ± 0.77 0.01 ± 0.15 0.5
Vessel CSA (mm2) 19.96 ± 5.65 19.85 ± 5.49 0.11 ± 1.24 0.4
Plaque CSA (mm2) 10.88 ± 2.84 10.85 ± 2.53 0.03 ± 1.34 0.2
Plaque burden (%) 56.07 ± 10.54 56.23 ± 10.33 0.17 ± 3.74 0.4
Plaque max. thickness (mm) 1.15 ± 0.36 1.16 ± 0.37 0.01 ± 0.24 0.7
(b). Matched segments (n = 21)
Average lumen CSA (mm2) 8.92 ± 3.90 8.87 ± 3.85 0.04 ± 0.44 0.8
Average vessel CSA (mm2) 19.64 ± 5.54 19.57 ± 5.44 0.07 ± 0.38 0.3
Average plaque CSA (mm2) 10.73 ± 2.29 10.70 ± 2.12 0.03 ± 0.44 0.1
Plaque burden (%) 56.15 ± 7.97 56.35 ± 8.16 0.20 ± 1.71 0.4
Minimum lumen area (mm2) 6.12 ± 2.80 5.93 ± 2.82 0.20 ± 0.69 4.1
Minimum lumen diameter (mm) 2.72 ± 0.64 2.63 ± 0.67 0.09 ± 0.24 3.7
Fig. 3 Bland-Altman plots of intra-observer comparisons for lumen, vessel, plaque area and plaque burden
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effect of medical therapies on coronary plaque size in
longitudinal studies [4–11]. Moreover, this method has the
potential to assess plaque composition and therefore to
assess the effect of drug therapies on the phenotype of
coronary atherosclerosis. As the impact of medical treat-
ment on the atherosclerotic plaque size and composition
over time is relatively small, highly reproducible CTCA
quantitative measurements are pivotal.
Geometrical measurements
In the present study, the CTCA geometrical measurements
were highly reproducible in both intra- and inter-observer
comparisons. Furthermore, in comparison with IVUS
studies, the CTCA reproducibility appears to be compara-
ble or better (Table 6). This improved reproducibility could
be partly attributed to the semi-automated manner of the
contouring in CTCA analysis. Another important consid-
eration is the methodology for the actual analysis, since in
CTCA all frames were analyzed in a stepwise approach;
first the lumen and vessel wall borders were delineated as
continuous lines in the longitudinal view (L-view). These
contour positions functioned as landmarks for the auto-
mated contour detection in the individual cross sections; a
visual inspection was performed in every cross-section and
a manual correction was applied if necessary. In contrast,
in IVUS only the individual cross-sections are drawn
without the first step (i.e. longitudinal drawing). An addi-
tional issue is the fact that in CTCA all frames of the
analyzed vessel are taken from the same cardiac cycle
phase, whereas in IVUS this varies from cross-section to
cross-section. In other words, in IVUS the frames are not
only scrambled images (due to the longitudinal movement
of the catheter inside the vessel), but also they are taken at
fixed distances (i.e. 0.5–1.0 mm) irrespective of the cardiac
cycle phase.
The moderate concordance correlation coefficient
between observers for the maximal wall thickness can be
mostly attributed to the fact that this parameter depends
highly on the shape of the lumen and vessel contour; a
small ‘‘bump’’ in one of the contours would not cause a
large difference in the area measurement but could sub-
stantially influence the plaque thickness.
Compositional measurements
Regarding the plaque composition, overall the differences
of the average plaque attenuation between observers were
very small on the cross-sectional and segment level anal-
yses. Despite this finding, the %LAP (\30 HU) showed a
relatively high inter-observer variability of 12 %, which is
of major significance since the temporal change of such
component could potentially become an imaging endpoint
of longitudinal studies. The LAP is probably the most
clinically relevant component of coronary plaques as it has
been shown to correlate closely with plaques of low ech-
ogenicity (presumably lipid rich) on IVUS [18] and to have
prognostic value for the development of acute coronary
syndromes [19]. On the other hand, the intra-observer
variability for %LAP was low (median 3 % approxi-
mately), which underlines the fact that the position of the
plaque contours can play a detrimental role in the distri-
bution of attenuation values. Small differences in the
lumen or vessel wall delineation would not dramatically
influence the geometrical measurements, but they could
result in much bigger differences in the compositional
measurements due to partial volume, i.e. in case part of the
lumen or the pericoronary fat is incorrectly included in the
plaque area.
Implications for the design of longitudinal studies
In the present study, the observer variability was lower than
the serial changes in plaque burden—the most common
endpoint in IVUS progression/regression studies. This
finding suggests that CTCA data analysis using semiauto-
mated software can detect changes in atherosclerotic pla-
que size beyond the observer bias. Certainly, the best
approach is that the same analyst analyzes in a blind
fashion both the baseline and follow-up CTCA images,
Table 5 Correlation between the 2 rounds of the same observer for
geometrical and compositional parameters
Geometrical and compositional parameters CCC 95 % CI
(a). Cross-sectional basis
Lumen area (mm2) 0.98 0.976–0.981
Lumen diameter (mm) 0.98 0.978–0.983
Vessel area (mm2) 0.98 0.972–0.980
Plaque area (mm2) 0.88 0.860–0.889
Plaque burden (%) 0.94 0.927–0.943
Maximal plaque thickness (mm) 0.79 0.762–0.810
Mean plaque attenuation (HU) 0.95 0.938–0.952
% LAP 0.82 0.798–0.840
(b). Segmental basis
Mean lumen area (mm2) 0.99 0.984–0.997
Mean vessel area (mm2) 0.99 0.994–0.999
Mean plaque area (mm2) 0.98 0.956–0.991
Plaque burden (%) 0.98 0.945–0.991
Minimal lumen area (mm2) 0.97 0.923–0.987
Minimal lumen diameter (mm) 0.93 0.826–0.968
Mean plaque attenuation (HU) 0.98 0.945–0.990
% LAP 0.96 0.909–0.984
CCC concordance correlation coefficient, CI confidence interval, LAP
low attenuation plaque
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since the difference is much lower in the intra-observer
comparison for both the cross-sectional and segment based
analyses than in the inter-observer comparison; more
importantly, for the compositional measurements only the
intra-observer variability was below the generally accept-
able threshold of 10 %.
It should be noted that the present study was conducted on
a population with mild-to-moderately diseased arteries
receiving contemporary medical therapy. This was driven by
the intention to study the reproducibility of this quantitative
method on patients that would be the most suitable candi-
dates for serial assessment of atherosclerosis in the ‘‘real
life’’; since the severe lesions would have been treated with
percutaneous coronary intervention, the efficacy of the statin
therapy would be monitored mainly in the untreated, mild-
to-moderately diseased atherosclerotic arteries.
Limitations
The studied population was small in terms of patients
included; nevertheless the geometric and compositional
analysis was performed on 945 matched cross-sections.
Furthermore, our analysis was restricted to good quality
images, which is a prerequisite for such precise CTCA
quantitative analysis. We did not control for patients’ char-
acteristics in the 3 year longitudinal study. Finally, the
analyzed vessels belong to a cohort of patients with mild-to-
moderately diseased arteries, thus our results may not apply
to other patient populations with different extent of disease;
however the patients used for this study would mostly benefit
from the serial assessment of atherosclerosis.
Conclusions
Considering the small changes in atherosclerotic plaque
over time, reproducibility of measurements is paramount
for the validity of longitudinal studies. The present study
shows that the geometrical assessment of coronary ath-
erosclerosis by CTCA is highly reproducible within and
between observers using semiautomated quantification
software. The compositional measurements were more
variable than geometrical measurements, especially
between different observers. The absolute observer vari-
ability was lower than the absolute detected serial changes
in plaque burden and plaque area after 3 years.
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